Andrew Huberman· PhD
No, amazingly it really hasn't. I mean there there's been some discussion about the risks of using these lentiviruses and we we'll talk in a second about how we can do better now.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
No, amazingly it really hasn't. I mean there there's been some discussion about the risks of using these lentiviruses and we we'll talk in a second about how we can do better now.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.